Pretransplant immunosuppression followed by reduced-toxicity conditioning and stem cell transplantation in high-risk thalassemia: a safe approach to disease control.
Anurathapan U, Pakakasama S, Rujkijyanont P, Sirachainan N, Songdej D, Chuansumrit A, Sirireung S, Charoenkwan P, Jetsrisuparb A, Issaragrisil S, Ungkanont A, Sruamsiri R, Srisala S, Andersson BS, Hongeng S.
Anurathapan U, et al. Among authors: songdej d.
Biol Blood Marrow Transplant. 2013 Aug;19(8):1259-62. doi: 10.1016/j.bbmt.2013.04.023. Epub 2013 May 3.
Biol Blood Marrow Transplant. 2013.
PMID: 23648235
Free PMC article.
Clinical Trial.